Ibopamine eyedrops in the treatment of hypotony after vitreoretinal surgery in retinal detachment or uveitis.
- Registration Number
- NL-OMON26464
- Brief Summary
gahary LC, Ganteris E, Veckeneer M, Cohen AC, Jansen J, Mulder PG, van Meurs JC. Topical ibopamine in the treatment of chronic ocular hypotony attributable to vitreoretinal surgery, uveitis, or penetrating trauma. Am J Ophthalmol. 2006;141(3):571-573.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 15
1. Hypotony (0-5 mm Hg);
2. Stable eye pressure for at least 4 months;
3. No reaction of eye pressure to atropine and steroids;
4. Continued steroid treatment during past six months;
5. Status after vitreoretinal surgery or uveitis.
1. Chronical heart failure;
2. Traction on corpus ciliare;
3. Cyclodialysis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ocular pressure on treatment day.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.